Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China.
Frequently asked questions
What sector does Ginwa Enterprise Group Inc (600080) operate in?
Ginwa Enterprise Group Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Ginwa Enterprise Group Inc (600080) current stock price?
As of the latest data, Ginwa Enterprise Group Inc stock price is CN¥4.61, with a previous close of CN¥4.61.
What is Ginwa Enterprise Group Inc (600080) current market capitalization?
Ginwa Enterprise Group Inc market cap is approximately 1.72 billion.
What is Ginwa Enterprise Group Inc (600080) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.03.
What is Ginwa Enterprise Group Inc (600080) Price-to-Earnings (P/E) ratio?
Ginwa Enterprise Group Inc current P/E ratio is 153.67.
What is Ginwa Enterprise Group Inc (600080) EBITDA?
Ginwa Enterprise Group Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.79 million.
Does Ginwa Enterprise Group Inc (600080) pay dividends?
No. Ginwa Enterprise Group Inc does not pay a dividend.
What is Ginwa Enterprise Group Inc (600080) beta (volatility) score?
Ginwa Enterprise Group Inc has a beta of 0.060, indicating lower volatility than the overall market.